Clinical Trials for Covaxin on 6-12 Age Group to Start from Tomorrow

New Delhi: The All India Institute of Medical Sciences (AIIMS) Delhi will start clinical trials of Bharat Biotech’s Covaxin for the 6-12 age group from Tuesday to evaluate the safety and efficacy of COVID-19 vaccine on children.

The enrolment of children volunteers aged 12-18 years at the AIIMS has been completed and they have been given the first dose of Covaxin, according to the reports.

Earlier, the Drugs Controller General of India (DCGI) had given its approval for conducting the phase 2/3 clinical trial of Covaxin among children aged two to 18 years on May 12.